Denna sida på svenska
Loading profile information...

About me

Lucas Morin is a doctoral student at the Aging Research Center (ARC), a division from the Department of Neurobiology, Care Sciences and Society at Karolinska Institutet. His research is mostly focused on pharmacoepidemiology and end-of-life care.

Before joining the Aging Research Center, Lucas was the Director of the French National Observatory on End-of-Life Care in Paris, France.

Research description

Areas of research

  • Use of potentially inadequate medical interventions at the end of life
  • Impact of spousal bereavement in old age
  • Quality of end-of-life care in nursing homes
  • Polyphamarcy and inappropriate drug use among older people


Thesis (2015-2019): "Drug prescribing in older people at the end of life"


Recent publications:

Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus.
Morin L, Laroche M, Vetrano D, Fastbom J, Johnell K
Eur. J. Clin. Pharmacol. 2018 Oct;74(10):1333-1342

The epidemiology of polypharmacy in older adults: register-based prospective cohort study.
Morin L, Johnell K, Laroche M, Fastbom J, Wastesson J
Clin Epidemiol 2018 ;10():289-298

Timing of palliative care needs reporting and aggressiveness of care near the end of life in metastatic lung cancer: A national registry-based study.
Goldwasser F, Vinant P, Aubry R, Rochigneux P, Beaussant Y, Huillard O, et al
Cancer 2018 Jul;124(14):3044-3051

Hospital end-of-life care in haematological malignancies.
Beaussant Y, Daguindau E, Chauchet A, Rochigneux P, Tournigand C, Aubry R, et al
BMJ Support Palliat Care 2018 Sep;8(3):314-324

Is the level of education associated with transitions between care settings in older adults near the end of life? A nationwide, retrospective cohort study.
Kelfve S, Wastesson J, Fors S, Johnell K, Morin L
Palliat Med 2018 02;32(2):366-375

Choosing Wisely? Measuring the Burden of Medications in Older Adults near the End of Life: Nationwide, Longitudinal Cohort Study.
Morin L, Vetrano D, Rizzuto D, Calderón-Larrañaga A, Fastbom J, Johnell K
Am. J. Med. 2017 08;130(8):927-936.e9

Discrepancies in the use of chemotherapy and artificial nutrition near the end of life for hospitalised patients with metastatic gastric or oesophageal cancer. A countrywide, register-based study.
Kempf E, Tournigand C, Rochigneux P, Aubry R, Morin L
Eur. J. Cancer 2017 07;79():31-40

Drug Use in Older Adults with Amyotrophic Lateral Sclerosis Near the End of Life.
Grande G, Morin L, Vetrano D, Fastbom J, Johnell K
Drugs Aging 2017 07;34(7):529-533

Use of Medications of Questionable Benefit During the Last Year of Life of Older Adults With Dementia.
Morin L, Vetrano D, Grande G, Fratiglioni L, Fastbom J, Johnell K
J Am Med Dir Assoc 2017 Jun;18(6):551.e1-551.e7

Use of chemotherapy near the end of life: what factors matter?
Rochigneux P, Raoul J, Beaussant Y, Aubry R, Goldwasser F, Tournigand C, et al
Ann. Oncol. 2017 04;28(4):809-817

Estimating the need for palliative care at the population level: A cross-national study in 12 countries.
Morin L, Aubry R, Frova L, MacLeod R, Wilson D, Loucka M, et al
Palliat Med 2017 06;31(6):526-536

Prevalence of Potentially Inappropriate Medication Use in Older Adults Living in Nursing Homes: A Systematic Review.
Morin L, Laroche M, Texier G, Johnell K
J Am Med Dir Assoc 2016 09;17(9):862.e1-9

Aggressiveness of End-of-Life Care for Hospitalized Individuals with Cancer with and without Dementia: A Nationwide Matched-Cohort Study in France.
Morin L, Beaussant Y, Aubry R, Fastbom J, Johnell K
J Am Geriatr Soc 2016 09;64(9):1851-7

End-of-life care for hospitalized patients with metastatic melanoma in France: a nationwide, register-based study.
Gallais Sérézal I, Beaussant Y, Rochigneux P, Tournigand C, Aubry R, Lindelöf B, et al
Br. J. Dermatol. 2016 Sep;175(3):583-92

Discussing end-of-life issues in nursing homes: a nationwide study in France.
Morin L, Johnell K, Van den Block L, Aubry R
Age Ageing 2016 05;45(3):395-402

Place of death in the population dying from diseases indicative of palliative care need: a cross-national population-level study in 14 countries.
Pivodic L, Pardon K, Morin L, Addington-Hall J, Miccinesi G, Cardenas-Turanzas M, et al
J Epidemiol Community Health 2016 Jan;70(1):17-24

A population-level study of place of death and associated factors in Sweden.
Håkanson C, Öhlén J, Morin L, Cohen J
Scand J Public Health 2015 Nov;43(7):744-51

Place of death of people living with Parkinson's disease: a population-level study in 11 countries.
Moens K, Houttekier D, Van den Block L, Harding R, Morin L, Marchetti S, et al
BMC Palliat Care 2015 May;14():28

Potentially inappropriate drug use in older people: a nationwide comparison of different explicit criteria for population-based estimates.
Morin L, Fastbom J, Laroche M, Johnell K
Br J Clin Pharmacol 2015 Aug;80(2):315-24

Variation in the place of death among nursing home residents in France.
Morin L, Johnell K, Aubry R
Age Ageing 2015 May;44(3):415-21

International variation in place of death of older people who died from dementia in 14 European and non-European countries.
Reyniers T, Deliens L, Pasman H, Morin L, Addington-Hall J, Frova L, et al
J Am Med Dir Assoc 2015 Feb;16(2):165-71


Other scientific activities

  • Co-chair of the “Big data in End-of-Life Care Research” task force of the European Association for Palliative Care (EAPC)
  • Member of the Scientific Committee for the 2019 Annual Congress of the European Association for Palliative Care
  • Member of the Scientific Committee for the 2019 Annual Congress of the French Association for Palliative Care (SFAP)
  • Member of the “Geriatric Pharmacoepidemiology” special interest group of the International Society for Pharmacoepidemiology (ISPE)



View map

Tomtebodavägen 18A